Clinical trials
Completed Psychotic Disorders trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heinrich-Heine University, Duesseldorf | 4 |
| Technical University of Munich | 4 |
| Central Institute of Mental Health, Mannheim | 3 |
| Philipps University Marburg | 3 |
| University of Konstanz | 3 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Charite University, Berlin, Germany | 2 |
| Rene Kahn | 2 |
| University of Cologne | 2 |
| ACADIA Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 37 |
| Schizophrenia | 29 |
| Hallucinations | 4 |
| Schizophrenia, Paranoid | 4 |
| Bipolar Disorder | 3 |
| Dementia | 2 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 2 |
| Alzheimer Disease | 1 |
| Cognition Disorders | 1 |
| Corticobasal Degeneration | 1 |
Trials
Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.